CHRISTINA HUMBERT: Open Payments
NPI 1235766312 · ASHEVILLE, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$986 in 46 payments from 15 companies in 2025. Trend: 2023 $0 · 2024 $285 · 2025 $986
Food & beverage: $986
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 4 | $307 |
| ABBVIE INC. | 21 | $247 |
| Indivior Inc. | 3 | $78 |
| Lilly USA, LLC | 3 | $63 |
| GlaxoSmithKline, LLC. | 3 | $59 |
| Novo Nordisk Inc | 3 | $50 |
| Gilead Sciences, Inc. | 1 | $29 |
| Seqirus USA Inc | 1 | $24 |
| Lundbeck LLC | 1 | $24 |
| Teva Pharmaceuticals USA, Inc. | 1 | $22 |
Products named: BREZTRI, VRAYLAR, AIRSUPRA, SUBLOCADE, MOUNJARO, TRELEGY ELLIPTA, UBRELVY, QULIPTA.
Industry payments across NC — which companies pay providers there.
